1. Home
  2. IMRX vs BZAI Comparison

IMRX vs BZAI Comparison

Compare IMRX & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.46

Market Cap

265.3M

Sector

Health Care

ML Signal

HOLD

Logo Blaize Holdings Inc.

BZAI

Blaize Holdings Inc.

HOLD

Current Price

$1.01

Market Cap

268.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRX
BZAI
Founded
2008
2010
Country
United States
United States
Employees
N/A
254
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.3M
268.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IMRX
BZAI
Price
$4.46
$1.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$17.20
$4.67
AVG Volume (30 Days)
752.0K
3.2M
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
37.75
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$239.02
Revenue Next Year
N/A
$45.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$0.74
52 Week High
$10.08
$6.76

Technical Indicators

Market Signals
Indicator
IMRX
BZAI
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
IMRX
BZAI

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About BZAI Blaize Holdings Inc.

Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.

Share on Social Networks: